财务利益冲突披露与支付数据库一致性评估:健康文献的系统调查
该系统调查检索 Medline 和 EMBASE 至 2017 年 2 月,纳入 27 篇评估财务利益冲突披露与支付数据库一致性的文章。作者披露不一致的中位百分比为 81%,完全不一致为 43%;企业不一致报告率在 23% 至 85% 之间。结论认为健康科学研究者财务利益冲突低报普遍存在,但纳入研究方法学局限可能高估了结果。
要点
- 作者披露与支付数据库不一致的中位百分比为 81%。
- 完全不一致披露的中位百分比为 43%。
- 企业利益冲突报告不一致率在 23% 至 85% 之间。
核心结论
- 健康科学研究者财务利益冲突的低报现象普遍存在。
- 评估利益冲突低报的研究存在多种局限,可能高估了其发现。
研究设计与样本
- 研究设计为健康文献的系统调查,检索 Medline 和 EMBASE 至 2017 年 2 月。
- 研究筛选、数据提取和方法学质量评估由两人独立重复完成,使用标准化表格。
- 共纳入 27 篇符合条件的期刊文章,主要评估已发表文章(n=13)和已发表指南(n=9)。
主要发现
- 作者披露不一致的中位百分比为 81%,完全不一致的中位百分比为 43%。
- 企业利益冲突报告不一致的百分比在 23% 至 85% 之间。
- 最常用的支付数据库是 Open Payments Database(n=16)。
- 纳入研究中仅 3 篇被判定为高质量研究。
- 一致性评估方法及结局标签和定义在纳入研究间差异很大。
局限性
- 纳入研究的方法学存在多种局限,可能高估了利益冲突低报的发现。
- 一致性评估方法及结局定义在纳入研究间差异很大。
- 仅 3 篇纳入研究被判定为高质量研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The objective of the study is to review the literature for studies that assessed the concordance of financial conflicts of interest disclosures with payments' databases and evaluate their methods. STUDY DESIGN AND SETTING: We conducted a systematic survey of the health literature to identify eligible studies. We searched both Medline and EMBASE up to February 2017. We conducted study selection, data abstraction, and methodological quality assessment in duplicate and independently using standardized forms. We subcategorized 'nonconcordant disclosures' as either 'partially nonconcordant' or 'completely nonconcordant'. The main outcome was the percentage of authors with 'nonconcordant' disclosures. We summarized results by three levels of analysis: authors, companies, and studies. RESULTS: We identified 27 eligible journal articles. The top two types of documents assessed were published articles (n = 13) and published guidelines (n = 9). The most commonly used payment database was the Open Payments Database (n = 16). The median percentage of authors with 'nonconcordant' disclosures was 81%; the median percentage was 43% for 'completely nonconcordant' disclosures. The percentage of 'nonconcordant' conflict of interest (COI) reporting by companies varied between 23% and 85%. The methods of concordance assessment, as well as the labeling and definitions of assessed outcomes varied widely across the included studies. We judged three of the included studies as high-quality studies. CONCLUSION: Underreporting of health science researchers' financial COIs is pervasive. Studies assessing COI underreporting suffer from a number of limitations that could have overestimated their findings.
引用
- El-Rayess H, Khamis AM, Haddad S, et al. Assessing concordance of financial conflicts of interest disclosures with payments' databases: a systematic survey of the health literature. J Clin Epidemiol. 2020. PMID: 32622901. doi:10.1016/j.jclinepi.2020.06.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。